| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Yao-Chen Zhang, Ke-Yi Fan, Qi Wang, Jing-Xi Hu, Qian Wang, He-Yi Zhang, Shan Song, Rong Zhao, Jun Qiao, Sheng-Xiao Zhan. Genetically Determined Levels of mTOR-Dependent Circulating Proteins and Risk of Multiple Sclerosis. Neurology and therapy. 2023-03-04. PMID:36870011. |
results from observational studies indicate an association between circulating levels of mammalian target of rapamycin (mtor)-dependent circulating proteins and the risk of multiple sclerosis (ms). |
2023-03-04 |
2023-08-14 |
Not clear |
| Yang Yang, Wei Song, Ning Wang, Yuqing Ren, Hongzhuo Li. Tip-concentrated microneedle patch delivering everolimus for therapy of multiple sclerosis. Biomaterials advances. vol 135. 2022-08-05. PMID:35929200. |
everolimus, as a new generation of mtor inhibitors, can effectively alleviate the inflammatory reaction of the central nervous system and offers a promising choice for the treatment of multiple sclerosis. |
2022-08-05 |
2023-08-14 |
Not clear |
| Aigli G Vakrakou, Anastasia Alexaki, Maria-Evgenia Brinia, Maria Anagnostouli, Leonidas Stefanis, Panos Stathopoulo. The mTOR Signaling Pathway in Multiple Sclerosis; from Animal Models to Human Data. International journal of molecular sciences. vol 23. issue 15. 2022-07-28. PMID:35897651. |
importantly, the study of mtor pathway contributions to autoimmune inflammatory demyelination and multiple sclerosis illustrates the difficulties in the clinical application of animal model results. |
2022-07-28 |
2023-08-14 |
human |
| Aigli G Vakrakou, Anastasia Alexaki, Maria-Evgenia Brinia, Maria Anagnostouli, Leonidas Stefanis, Panos Stathopoulo. The mTOR Signaling Pathway in Multiple Sclerosis; from Animal Models to Human Data. International journal of molecular sciences. vol 23. issue 15. 2022-07-28. PMID:35897651. |
the mtor signaling pathway in multiple sclerosis; from animal models to human data. |
2022-07-28 |
2023-08-14 |
human |
| Aigli G Vakrakou, Anastasia Alexaki, Maria-Evgenia Brinia, Maria Anagnostouli, Leonidas Stefanis, Panos Stathopoulo. The mTOR Signaling Pathway in Multiple Sclerosis; from Animal Models to Human Data. International journal of molecular sciences. vol 23. issue 15. 2022-07-28. PMID:35897651. |
this article recapitulates the evidence on the role of mammalian targets of rapamycin (mtor) complex pathways in multiple sclerosis (ms). |
2022-07-28 |
2023-08-14 |
human |
| Kenneth Maies. Novel Insights for Multiple Sclerosis and Demyelinating Disorders with Apoptosis, Autophagy, FoxO, and mTOR. Current neurovascular research. vol 18. issue 2. 2021-11-08. PMID:33964865. |
novel insights for multiple sclerosis and demyelinating disorders with apoptosis, autophagy, foxo, and mtor. |
2021-11-08 |
2023-08-13 |
Not clear |
| Fahimeh Akbarian, Mohammad Amin Tabatabaiefar, Vahid Shaygannejad, Mohammad Mahdi Shahpouri, Negin Badihian, Roshanak Sajjadi, Arezou Dabiri, Nazanin Jalilian, Mohammad Reza Noori-Daloi. Upregulation of MTOR, RPS6KB1, and EIF4EBP1 in the whole blood samples of Iranian patients with multiple sclerosis compared to healthy controls. Metabolic brain disease. vol 35. issue 8. 2021-09-02. PMID:32809098. |
upregulation of mtor, rps6kb1, and eif4ebp1 in the whole blood samples of iranian patients with multiple sclerosis compared to healthy controls. |
2021-09-02 |
2023-08-13 |
Not clear |
| Cinzia Dello Russo, Lucia Lisi, Douglas L Feinstein, Pierluigi Navarr. mTOR kinase, a key player in the regulation of glial functions: relevance for the therapy of multiple sclerosis. Glia. vol 61. issue 3. 2013-07-03. PMID:23044764. |
mtor kinase, a key player in the regulation of glial functions: relevance for the therapy of multiple sclerosis. |
2013-07-03 |
2023-08-12 |
Not clear |